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Nucleus Cytoplasm Nucleus Cytoplasm Nucleus Cytoplasm
NO v NG 1 1 0.375 * * *
NO v ND BO 0.019 <0.001 1 0.584 * *
NO v D BO 0.579 <0.001 <0.001 <0.001 * *
NO v ND BO p-dys 0.568 <0.001 0.014 0.002 * *
NO v ND BO p- OAC 1 0.295 1 * * *
NG v ND BO 0.018 <0.001 0.187 0.333 * *
NG v D BO 0.622 <0.001 <0.001 <0.001 * *
NG v ND BO p-dys 0.609 <0.001 <0.001 <0.001 * *
NG v ND BO p-OAC 1 0.102 * * * *
ND BO v D BO 0.137 0.177 <0.001 <0.001 * *
ND BO v ND BO p-dys 0.211 0.509 0.001 0.001 * *
ND BO v ND BO p-OAC 0.261 0.015 0.588 0.585 * *
D BO v ND BO p-dys 1 0.598 0.05 0.462 * *
D BO v ND BO p-OAC 1 0.004 <0.001 <0.001 * *
ND BO p-dys v ND BO p-OAC 1 0.023 0.006 0.006 * *
OAC v NO 0.116 0.002 0.002 1 1 *
OAC v NG 0.099 <0.001 <0.001 1 1 *
OAC v ND BO 0.232 0.001 <0.001 0.013 0.294 *
OAC v D BO 0.514 0.002 0.006 <0.001 1 *
OAC v ND BO p-dys 0.515 0.019 1 <0.001 1 *
OAC v ND BO p-OAC 0.682 0.49 0.001 1 1 *
Oesophageal adenocarcinoma
Pre-malignant 






















I (a/b) 13 (22%)
II (a/b) 19 (33%)
III 26 (45%)
IV 0 (0%)
Received Chemotherapy 7 (13%)






Alive >30 days 48 (84%)









2Number of Patients (%) p
Age at diagnosis*
0.515 0.473
No data are available for *1, **5 and ***23 patients.










Antibody target Antibody type Antigen retrieval buffer Dilution Positive control Supplier Code Isotype, clone
HMGB1 rabbit monoclonal citrate 1:400 colorectal cancer abcam ab79823 IgG, EPR3507
p53 mouse monoclonal EDTA 1:250 colorectal cancer abcam ab1101 IgG2a, DO-1
RUNX3 mouse monoclonal EDTA 1:500 colorectal cancer abcam ab40278 IgG1, R3-5G4
CD20+ B-cells mouse monoclonal citrate 1:600 tonsil Agilent Technologies M 075529-2 IgG2a, L26
CD4+ T-cells mouse monoclonal EDTA 1:500 tonsil abcam ab133616 IgG, EPR6855
CD8+ T-cells mouse monoclonal EDTA 1:150 tonsil abcam ab17147 IgG1, 144B
Foxp3+ T-cells (Tregs) mouse monoclonal EDTA 1:200 tonsil abcam ab20034 IgG1, 236A/E7
Table 2: Characteristics of the antibodies used for immunohistochemistry
Note: Citrate buffer at pH 6 and ethylenediaminetetraacetic acid (EDTA) at pH 7.8
𝞆𝞆2 p 𝞆𝞆2 p 𝞆𝞆2 p 𝞆𝞆2 p 𝞆𝞆2 p 𝞆𝞆2 p 𝞆𝞆2 p 𝞆𝞆2 p
NO v NG 4.811 0.078 2.320 0.652 * * - 0.543 - 1.000 - 1.000 - 0.052 - 1.000 - -
NO v ND BO 18.257 <0.001 32.086 <0.001 - 1.000 - <0.001 - 0.019 - <0.001 - <0.001 - 0.338 NO < ND BO NO < ND BO
NO v D BO 0.885 0.303 24.723 <0.001 * * - 0.001 - 0.579 - <0.001 - 0.674 - <0.001 - NO < D BO
NO v ND BO p-dys 1.052 0.270 19.497 <0.001 * * - 0.001 - 0.568 - <0.001 - 0.669 - 0.183 - NO < ND BO p-dys
NO v ND BO p- OAC 1.452 0.283 3.109 0.437 * * - 0.420 - 1.000 - 0.295 - 0.367 - 0.333 - -
NG v ND BO 8.339 0.028 42.153 <0.001 - 1.000 - <0.001 - 0.018 - <0.001 - 0.028 - 0.675 NG < ND BO NG < ND BO
NG v D BO 3.278 0.164 28.841 <0.001 * * - 0.003 - 0.622 - <0.001 - 0.318 - 0.001 - NG < D BO
NG v ND BO p-dys 2.930 0.268 24.883 <0.001 * * - 0.003 - 0.609 - <0.001 - 0.317 - 0.289 - NG < ND BO p-dys
NG v ND BO p-OAC 1.153 0.520 3.716 0.264 * * - 0.704 - 1.000 - 0.102 - 0.697 - 0.465 - -
ND BO v D BO 10.745 0.008 13.196 0.002 - 1.000 - 1.000 - 0.137 - 0.177 - 0.002 - <0.001 ND BO < D BO ND < D BO
ND BO v ND BO p-dys 9.417 0.017 0.872 0.887 - 1.000 - 1.000 - 0.211 - 0.509 - 0.004 - 0.631 ND BO < ND BO p-dys -
ND BO v ND BO p-OAC 5.625 0.164 10.397 0.008 - 1.000 - 0.015 - 0.261 - 0.015 - 0.024 - 1.000 ND BO < ND BO p-OAC ND BO > ND BO p-OAC
D BO v ND BO p-dys 0.269 1.000 4.839 0.072 * * - * - 1.000 - 0.598 - 1.000 - 0.050 - D BO > ND BO p-dys
D BO v ND BO p-OAC 0.625 0.822 9.591 0.015 * * - 0.042 - 1.000 - 0.004 - 1.000 - 0.080 - D BO > ND BO p-OAC
ND BO p-dys v ND BO p-OAC 0.542 1.000 7.680 0.027 * * - 0.047 - 1.000 - 0.023 - 1.000 - 1.000 - ND BO p-dys > ND BO p-OAC
OAC v NO 17.973 <0.001 15.788 0.001 - 1.000 - <0.001 - 0.116 - 0.002 - <0.001 - 0.040 OAC < NO OAC > NO
OAC v NG 5.630 0.111 17.701 <0.001 - 0.581 - 0.004 - 0.099 - <0.001 - 0.030 - 0.044 OAC < NG OAC > NG
OAC v ND BO 4.023 0.257 24.814 <0.001 - 0.392 - 0.037 - 0.232 - 0.001 - 1.000 - 0.039 - OAC < ND BO
OAC v D BO 10.931 0.008 10.727 0.008 - 1.000 - 0.209 - 0.514 - 0.002 - 0.001 - 0.022 OAC < D BO OAC < D BO
OAC v ND BO p-dys 9.543 0.017 8.844 0.020 - 1.000 - 0.209 - 0.515 - 0.019 - 0.002 - 0.731 OAC < ND BO p-dys OAC < ND BO p-dys
OAC v ND BO p-OAC 4.782 0.142 2.245 0.563 - 1.000 - 0.152 - 0.682 - 0.490 - 0.024 - 0.682 OAC < ND BO p-OAC -
Nucleus Cytoplasm Nucleus
Oesophageal adenocarcinoma
Note. *no statistics are computed because one variable is a constant. - no Chi square value is provided as test was with a 2X2 contingency table
Cytoplasm
Pre-malignant comparisons
Table S3: Association between HMGB1 and histological diagnosis; extended analysis
Strong v absent, weak and moderate
Nuclear Relationship Cytoplasmic Relationship
Nucleus Cytoplasm
Comparrisons
Absent v weak v moderate v strong Absent v weak, moderate and strong Absent and weak v moderate and 
Nucleus Cytoplasm
𝞆𝞆2 p 𝞆𝞆2 p 𝞆𝞆2 p 𝞆𝞆2 p 𝞆𝞆2 p 𝞆𝞆2 p 𝞆𝞆2 p 𝞆𝞆2 p
NO v NG 2.975 0.139 - 0.278 - 0.139 - 0.278 - 0.375 - * - 0.375 * * - -
NO v ND BO 12.269 0.003 9.986 0.004 - 0.003 - 0.001 - 1.000 - 0.584 - 0.310 * * NO < ND BO NO < ND BO
NO v D BO 20.483 <0.001 27.289 <0.001 - <0.001 - <0.001 - <0.001 - <0.001 - 0.002 - 0.002 NO < D BO NO < D BO
NO v ND BO p-dys 8.561 0.010 25.755 <0.001 - 0.009 - <0.001 - 0.014 - 0.002 - 0.014 - 0.042 NO < ND BO p-dys NO < ND BO p-dys
NO v ND BO p- OAC 1.881 0.372 * * - 0.670 * * - 1.000 * * - 1.000 * * - -
NG v ND BO 28.200 <0.001 5.391 0.057 - <0.001 - 0.028 - 0.187 - 0.333 - 1.000 * * NG < ND BO NG < ND BO
NG v D BO 36.226 <0.001 28.741 <0.001 - <0.001 - <0.001 - <0.001 - <0.001 - <0.001 - <0.001 NG < D BO NG < D BO
NG v ND BO p-dys 20.509 <0.001 24.677 <0.001 - <0.001 - <0.001 - <0.001 - <0.001 - <0.001 - 0.012 NG < ND BO p-dys NG < ND BO p-dys
NG v ND BO p-OAC - 0.038 - 0.278 - 0.038 - 0.278 * * * * * * * * NG < ND BO p-OAC -
ND BO v D BO 41.842 <0.001 35.538 <0.001 - 0.031 - <0.001 - <0.001 - <0.001 - <0.001 - <0.001 ND BO < D BO ND BO < D BO
ND BO v ND BO p-dys 23.019 <0.001 23.548 <0.001 - 0.762 - 0.001 - 0.001 - 0.001 - <0.001 - <0.001 ND BO < ND BO p-dys ND BO < ND BO p-dys
ND BO v ND BO p-OAC 4.747 0.186 8.468 0.010 - 0.035 - 0.003 - 0.588 - 0.585 - 1.000 * * ND BO > ND BO p-OAC ND BO > ND BO p-OAC
D BO v ND BO p-dys 5.679 0.140 2.164 0.723 - 0.169 - 1.000 - 0.050 - 0.462 - 0.462 - 0.264 D BO > ND BO p-dys -
D BO v ND BO p-OAC 21.732 <0.001 24.793 <0.001 - 0.001 - <0.001 - <0.001 - <0.001 - <0.001 - 0.002 D BO > ND BO p-OAC D BO > ND BO p-OAC
ND BO p-dys v ND BO p-OAC 9.312 0.010 23.380 <0.001 - 0.057 - <0.001 - 0.006 - 0.006 - 0.006 - 0.098 ND BO p-dys > ND BO p-OAC ND BO p-dys > ND BO p-OAC
OAC v NO 9.671 0.014 0.832 1.000 - 0.005 - 1.000 0.002 - 1.000 - 0.019 * * OAC > NO -
OAC v NG 27.987 <0.001 4.877 0.102 - <0.001 - 0.070 <0.001 - 1.000 - <0.001 * * OAC > NG -
OAC v ND BO 63.012 <0.001 39.655 <0.001 - 0.652 - <0.001 <0.001 - 0.013 - 0.001 * * OAC > ND BO OAC < ND BO
OAC v D BO 8.717 0.019 64.602 <0.001 - 0.010 - <0.001 0.006 - <0.001 - 0.051 - <0.001 OAC < D BO OAC < D BO
OAC v ND BO p-dys 2.834 0.416 57.393 <0.001 - 0.565 - <0.001 1.000 - <0.001 - 0.404 - <0.001 - OAC < ND BO p-dys
OAC v ND BO p-OAC 12.355 0.003 0.877 1.000 - 0.073 - 1.000 0.001 - 1.000 - 0.004 * * OAC > ND BO p-dys -
Table S4: Association between p53 and histological diagnosis; extended analysis
Comparrisons
Absent v weak v moderate v strong Absent v weak, moderate and strong Absent and weak v moderate and strong Strong v absent, weak and moderate




Note. *no statistics are computed because one variable is a constant. - no Chi square value is provided as test was with a 2X2 contingency table
Nucleus Cytoplasm Nucleus Cytoplasm Nucleus Cytoplasm
𝞆𝞆2 p 𝞆𝞆2 p 𝞆𝞆2 p 𝞆𝞆2 p 𝞆𝞆2 p 𝞆𝞆2 p 𝞆𝞆2 p 𝞆𝞆2 p
NO v NG * * - 1.000 * * - 1.000 * * * * * * * * - -
NO v ND BO - 1.000 * * - 1.000 * * * * * * * * * * - -
NO v D BO - 0.013 - 0.455 - 0.013 - 0.455 * * * * * * * * NO < D BO -
NO v ND BO p-dys - 0.010 - 0.028 - 0.010 - 0.028 * * * * * * * * NO < ND BO p-dys NO < ND BO p-dys
NO v ND BO p- OAC * * * * * * * * * * * * * * * * - -
NG v ND BO - 1.000 - 0.276 - 1.000 - 0.276 * * * * * * * * - -
NG v D BO - 0.004 - 1.000 - 0.004 - 1.000 * * * * * * * * NG < D BO
NG v ND BO p-dys - 0.003 - 0.039 - 0.003 - 0.039 * * * * * * * * NG < ND BO p-dys NG < ND BO p-dys
NG v ND BO p-OAC * * - 1.000 * * - 1.000 * * * * * * * * - -
ND BO v D BO - 0.001 - 0.174 - 0.001 - 0.174 * * * * * * * * ND BO < D BO -
ND BO v ND BO p-dys - 0.001 - <0.001 - 0.001 - <0.001 * * * * * * * * ND BO < ND BO p-dys ND BO < ND BO p-dys
ND BO v ND BO p-OAC - 1.000 * * - 1.000 * * * * * * * * * * - -
D BO v ND BO p-dys - 1.000 - 0.169 - 1.000 - 0.169 * * * * * * * * - -
D BO v ND BO p-OAC - 0.053 - 1.000 - 0.053 - 1.000 * * * * * * * * - -
ND BO p-dys v ND BO p-OAC - 0.046 - 0.105 - 0.046 - 0.105 * * * * * * * * ND BO p-dys > ND BO p-OAC -
OAC v NO 0.342 1.000 * * * * * * - 1.000 * * * * * * - -
OAC v NG 0.407 1.000 - 1.000 - 0.586 - 0.185 - 1.000 * * * * * * - -
OAC v ND BO 1.789 0.416 * * - 1.000 * * - 0.294 * * * * * * - -
OAC v D BO 15.943 <0.001 - 0.112 - 0.002 - 0.112 - 1.000 * * * * * * OAC < D BO -
OAC v ND BO p-dys 16.708 <0.001 - <0.001 - 0.001 - <0.001 - 1.000 * * * * * * OAC < ND BO p-dys OAC < ND BO p-dys
OAC v ND BO p-OAC 0.586 1.000 * * - 1.000 * * - 1.000 * * * * * * - -
Cytoplasm
Note: *no statistics are computed because one variable is a constant. - no Chi square value is provided as test was with a 2X2 contingency table
Table S5: Association between RUNX3 and histological diagnosis; extended analysis
Comparrisons
Absent v weak v moderate v strong Absent v weak, moderate and strong Absent and weak v moderate and strong Strong v absent, weak and moderate




Nucleus Cytoplasm Nucleus Cytoplasm Nucleus
0 v 1, 2, 3 0, 1 v 2 3 3 v 0, 1, 2
𝞆𝞆
2
p p p p
HMGB1 Nuclear vs. HMGB1 Cytoplasmic 19.473 0.021 0.598 0.098 0.482
HMGB1 Nuclear vs. p53 Nuclear 7.655 0.569 0.412 0.432 0.767
HMGB1 Nuclear vs. RUNX3 Nuclear 10.391 0.109 1 0.34  - 
p53 Nuclear vs. p53 Cytoplasmic 81.159 <0.001 <0.001 <0.001 <0.001
p53 Nuclear vs. RUNX3 Nuclear 22.871 0.001 0.002 0.024  - 
RUNX3 Nuclear vs. RUNX3 Cytoplasmic 85.269 <0.001 <0.001  -  - 
HMGB1 Cytoplasmic vs. p53 Cytoplasmic 25.13 0.003 0.004 0.013 0.018
HMGB1 Cytoplasmic vs. RUNX3 Cytoplasmic 3.308 0.347 1  -  - 
p53 Cytoplasmic vs. RUNX3 Cytoplasmic 44.32 <0.001 0.001  -  - 
HMGB1 Cytoplasmic vs. p53 Nuclear 15.768 0.072 0.002 0.493 0.127
HMGB1 Cytoplasmic vs. RUNX3 Nuclear 8.336 0.205 0.085 0.688  - 
HMGB1 Nuclear vs. HMGB1 Cytoplasmic 2.88 0.578  - 1  - 
HMGB1 Nuclear vs. p53 Nuclear 0.294 0.863  -  - 1
HMGB1 Nuclear vs. RUNX3 Nuclear  -  -  -  -  - 
p53 Nuclear vs. p53 Cytoplasmic  -  -  -  -  - 
p53 Nuclear vs. RUNX3 Nuclear  -  -  -  -  - 
RUNX3 Nuclear vs. RUNX3 Cytoplasmic  -  -  -  -  - 
HMGB1 Cytoplasmic vs. p53 Cytoplasmic  -  -  -  -  - 
HMGB1 Cytoplasmic vs. RUNX3 Cytoplasmic  -  -  -  -  - 
p53 Cytoplasmic vs. RUNX3 Cytoplasmic  -  -  -  -  - 
HMGB1 Cytoplasmic vs. p53 Nuclear 5.091 0.264 0.209  -  - 
HMGB1 Cytoplasmic vs. RUNX3 Nuclear  -  -  -  -  - 
HMGB1 Nuclear vs. HMGB1 Cytoplasmic 25.055 0.003 1 0.006 0.008
HMGB1 Nuclear vs. p53 Nuclear 16.647 0.055 1 0.136 0.001
HMGB1 Nuclear vs. RUNX3 Nuclear 7.601 0.055 1  -  - 
p53 Nuclear vs. p53 Cytoplasmic 87.008 <0.001 <0.001 <0.001 <0.001
p53 Nuclear vs. RUNX3 Nuclear 35.004 <0.001 0.053  -  - 
RUNX3 Nuclear vs. RUNX3 Cytoplasmic 43.196 <0.001 <0.001  -  - 
HMGB1 Cytoplasmic vs. p53 Cytoplasmic 16.218 0.062 1 0.778 0.004
HMGB1 Cytoplasmic vs. RUNX3 Cytoplasmic 1.134 0.72 1  -  - 
p53 Cytoplasmic vs. RUNX3 Cytoplasmic 21.534 <0.001 0.057  -  - 
HMGB1 Cytoplasmic vs. p53 Nuclear 24.531 0.005 0.112 0.036 0.074
HMGB1 Cytoplasmic vs. RUNX3 Nuclear 0.583 1 1  -  - 
HMGB1 Nuclear vs. HMGB1 Cytoplasmic 22.723 0.007 1 0.001 0.379
HMGB1 Nuclear vs. p53 Nuclear 9.588 0.385 1 1 1
HMGB1 Nuclear vs. RUNX3 Nuclear 1.08 0.782 1  -  - 
p53 Nuclear vs. p53 Cytoplasmic 25.891 <0.001 <0.001 0.096  - 
p53 Nuclear vs. RUNX3 Nuclear 6.653 0.084 1  -  - 
RUNX3 Nuclear vs. RUNX3 Cytoplasmic  -  -  -  -  - 
HMGB1 Cytoplasmic vs. p53 Cytoplasmic 8.159 0.227 0.166 0.134  - 
HMGB1 Cytoplasmic vs. RUNX3 Cytoplasmic  -  -  -  -  - 
p53 Cytoplasmic vs. RUNX3 Cytoplasmic  -  -  -  -  - 
HMGB1 Cytoplasmic vs. p53 Nuclear 12.271 0.192 1 1 1
All Barrett’s oesophagus 
All Non-dysplastic Barrett’s oesophagus 
0 v 1 v 2 v 3
All Oesophageal Tissue (normal, Barrett’s, dysplasia and cancer)
Normal Oesophagus
Table S6: Association between HMGB1, p53 and RUNX3 protein expression
HMGB1 Cytoplasmic vs. RUNX3 Nuclear 3.855 0.278 1  -  - 
HMGB1 Nuclear vs. HMGB1 Cytoplasmic 3.949 0.413  - 1 0.282
HMGB1 Nuclear vs. p53 Nuclear 9.909 0.129  - 1 0.56
HMGB1 Nuclear vs. RUNX3 Nuclear 5.182 0.075  -  -  - 
p53 Nuclear vs. p53 Cytoplasmic 19.375 0.022 1 1 0.007
p53 Nuclear vs. RUNX3 Nuclear 3.75 0.29 1  -  - 
RUNX3 Nuclear vs. RUNX3 Cytoplasmic 2.143 0.143 0.333  -  - 
HMGB1 Cytoplasmic vs. p53 Cytoplasmic 8.984 0.174  - 1 0.619
HMGB1 Cytoplasmic vs. RUNX3 Cytoplasmic 15 <0.001  -  -  - 
p53 Cytoplasmic vs. RUNX3 Cytoplasmic 6.964 0.073 1  -  - 
HMGB1 Cytoplasmic vs. p53 Nuclear 3.833 0.699  - 1 0.608
HMGB1 Cytoplasmic vs. RUNX3 Nuclear 4.313 0.116  -  -  - 
HMGB1 Nuclear vs. HMGB1 Cytoplasmic 3.36 0.499  - 1 1
HMGB1 Nuclear vs. p53 Nuclear 6.8 0.147  - 0.462 0.559
HMGB1 Nuclear vs. RUNX3 Nuclear 3.111 0.211  -  -  - 
p53 Nuclear vs. p53 Cytoplasmic 5.875 0.437 0.286 0.286 0.559
p53 Nuclear vs. RUNX3 Nuclear 3.63 0.163 0.221  -  - 
RUNX3 Nuclear vs. RUNX3 Cytoplasmic 10.08 0.001 0.005  -  - 
HMGB1 Cytoplasmic vs. p53 Cytoplasmic 4.9 0.557  - 0.462 0.505
HMGB1 Cytoplasmic vs. RUNX3 Cytoplasmic 2.24 0.326  -  -  - 
p53 Cytoplasmic vs. RUNX3 Cytoplasmic 5.833 0.12 1  -  - 
HMGB1 Cytoplasmic vs. p53 Nuclear 12.367 0.015  -  - 0.462
HMGB1 Cytoplasmic vs. RUNX3 Nuclear 1.369 0.504  -  -  - 
HMGB1 Nuclear vs. HMGB1 Cytoplasmic 4 0.677  - 1 1
HMGB1 Nuclear vs. p53 Nuclear 0.875 0.646  -  -  - 
HMGB1 Nuclear vs. RUNX3 Nuclear  -  -  -  -  - 
p53 Nuclear vs. p53 Cytoplasmic  -  -  -  -  - 
p53 Nuclear vs. RUNX3 Nuclear  -  -  -  -  - 
RUNX3 Nuclear vs. RUNX3 Cytoplasmic  -  -  -  -  - 
HMGB1 Cytoplasmic vs. p53 Cytoplasmic  -  -  -  -  - 
HMGB1 Cytoplasmic vs. RUNX3 Cytoplasmic  -  -  -  -  - 
p53 Cytoplasmic vs. RUNX3 Cytoplasmic  -  -  -  -  - 
HMGB1 Cytoplasmic vs. p53 Nuclear 7 0.072 1  -  - 
HMGB1 Cytoplasmic vs. RUNX3 Nuclear  -  -  -  -  - 
HMGB1 Nuclear vs. HMGB1 Cytoplasmic 20.312 0.016 1 0.815 0.787
HMGB1 Nuclear vs. p53 Nuclear 10.197 0.335 0.293 0.816 0.491
HMGB1 Nuclear vs. RUNX3 Nuclear 3.289 0.772 1 1  - 
p53 Nuclear vs. p53 Cytoplasmic 47.82 <0.001 0.08 1  - 
p53 Nuclear vs. RUNX3 Nuclear 16.142 0.013 0.647 0.612  - 
RUNX3 Nuclear vs. RUNX3 Cytoplasmic  -  -  -  -  - 
HMGB1 Cytoplasmic vs. p53 Cytoplasmic 4.717 0.581 0.589 1  - 
HMGB1 Cytoplasmic vs. RUNX3 Cytoplasmic  -  -  -  -  - 
p53 Cytoplasmic vs. RUNX3 Cytoplasmic  -  -  -  -  - 
HMGB1 Cytoplasmic vs. p53 Nuclear 5.664 0.773 0.37 0.242 1
HMGB1 Cytoplasmic vs. RUNX3 Nuclear 12.936 0.044 1 1  - 
Note: - no Chi square value is provided as test was with a 2X2 contingency table
Dysplastic Barrett’s oesophagus
Non-dysplastic Barrett’s oesophagus in patients who have progressed to dysplasia
Non-dysplastic Barrett’s oesophagus in patients who have progressed to adenocarcinoma 
Oesophageal Adenocarcinoma
Histology Number of samples Median number of positive cells (SD) 25th percentile 75th percentile
NO 10 14 (23.300) 5.75 45.75
NG 15 45 (38.221) 34 71
ND BO 70 0 (1.326) 0 0
D BO 13 0 (5.294) 0 7
ND BO p-dys 14 0 (4.480) 0 3.25
ND BO p-OAC 14 2 (15.745) 0 15.5
NO 18 80 (66.261) 53.5 141.75
NG 18 57 (46.390) 26.75 92.5
ND BO 56 21 (21.186) 11 35.25
D BO 15 26 (39.071) 14 53
ND BO p-dys 12 20.50 (34.630) 12.25 68.25
ND BO p-OAC 11 35 (27.359) 31 64
NO 13 80 (55.073) 49.5 114.5
NG 33 89 (53.242) 65.5 102.5
ND BO 61 16 (17.787) 7 34.5
D BO 15 31 (66.966) 17 89
ND BO p-dys 14 33.50 (41.589) 7.5 61.5
ND BO p-OAC 22 33 (27.399) 11.75 66.25
NO 19 9 (16.305) 1 30
NG 16 5.50 (11.615) 2 10
ND BO 57 9 (10.348) 3 17
D BO 15 36 (34.117) 22 68
ND BO p-dys 13 11 (26.878) 3 33





Table S7: CD20+, CD4+, CD8+ and FOXP3+ lymphocytes in pre-malignant oesophageal neoplastic progression
Comparisons Mann Whitney-U p Relationship
NO v NG 41.5 0.063 -
NO v ND BO 15 <0.001 NO > ND BO
NO v D BO 19.5 0.004 NO > D BO
NO v ND BO p-dys 14.5 0.001 NO > ND BO p-dys
NO v ND BO p-OAC 32 0.025 NO > ND BO p-OAC
NG v ND BO 48 <0.001 NG > ND BO
NG v D BO 15.5 <0.001 NG > D BO
NG v ND BO p-dys 14.5 <0.001 NG > ND BO p-dys
NG v ND BO p-OAC 28 <0.001 NG > ND BO p-OAC
ND BO v D BO 289 0.003 ND BO < D BO
ND BO v ND BO p-dys 374.5 0.038 ND BO < ND BO p-dys
ND BO v ND BO p-OAC 231 <0.001 ND BO < ND BO p-OAC
D BO v ND BO p-dys 78 0.478 -
D BO v ND BO p-OAC 76 0.445 -
ND BO p-dys v ND BO p-OAC 70.5 0.176 -
NO v NG 110 0.1 -
NO v ND BO 11713 <0.001 NO > ND BO
NO v D BO 54 0.003 NO > D BO
NO v ND BO p-dys 42.5 0.006 NO > ND BO p-dys
NO v ND BO p-OAC 50.5 0.029 NO > ND BO p-OAC
NG v ND BO 219.5 <0.001 NG > ND BO
NG v D BO 82.5 0.058 -
NG v ND BO p-dys 60.5 0.044 NG > ND BO p-dys
NG v ND BO p-OAC 83 0.472 -
ND BO v D BO 364 0.43 -
ND BO v ND BO p-dys 303 0.595 -
ND BO v ND BO p-OAC 131 0.003 ND BO < ND BO p-OAC
D BO v ND BO p-dys 83.5 0.751 -
D BO v ND BO p-OAC 54 0.138 -
ND BO p-dys v ND BO p-OAC 35 0.056 -
NO v NG 187 0.502 -
NO v ND BO 27.5 <0.001 NO > ND BO
NO v D BO 55.5 0.053 -
NO v ND BO p-dys 30 0.003 NO > ND BO p-dys
NO v ND BO p-OAC 42 0.001 NO > ND BO p-OAC
NG v ND BO 61.5 <0.001 NG > ND BO
NG v D BO 125 0.007 NG > D BO
NG v ND BO p-dys 67 <0.001 NG > ND BO p-dys




Table S8: Association between lymphocyte populations and histological cell types.
ND BO v D BO 265 0.012 ND BO < D BO
ND BO v ND BO p-dys 311.5 0.116 -
ND BO v ND BO p-OAC 432 0.014 ND BO < ND BO p-OAC
D BO v ND BO p-dys 90 0.513 -
D BO v ND BO p-OAC 139 0.421 -
ND BO p-dys v ND BO p-OAC 147 0.82 -
NO v NG 119.5 0.28 -
NO v ND BO 515 0.75 -
NO v D BO 54.5 0.002 NO < D BO
NO v ND BO p-dys 111.5 0.644 -
NO v ND BO p-OAC 151 0.974 -
NG v ND BO 356 0.181 -
NG v D BO 24 <0.001 NG < D BO
NG v ND BO p-dys 72 0.159 -
NG v ND BO p-OAC 108 0.45 -
ND BO v D BO 108.5 <0.001 ND BO < D BO
ND BO v ND BO p-dys 310.5 0.364 -
ND BO v ND BO p-OAC 452 0.957 -
D BO v ND BO p-dys 48 0.023 D BO > ND BO p-dys
D BO v ND BO p-OAC 44 0.003 D BO > ND BO p-OAC
ND BO p-dys v ND BO p-OAC 86 0.429 -
Foxp3+ T-cells (Tregs)

Novel biomarkers for risk stratification of Barrett’s oesophagus associated neoplastic 
progression - epithelial HMGB1 expression and stromal lymphocytic phenotype 
 
Figure legend Figure S1  
 
Representative high power field photomicrographs representing (A) strong nuclear and 
absent cytoplasmic HMGB1 expression in normal oesophageal epithelium, (B) absent nuclear 
and weak cytoplasmic HMGB1 expression in non-dysplastic BO epithelium, (C) absent nuclear 
and moderate cytoplasmic HMGB1 expression in OAC, (D) strong nuclear and strong 
cytoplasmic HMGB1 expression in OAC, (E) weak nuclear p53 in non-dysplastic BO epithelium, 
(F) strong nuclear and moderate cytoplasmic p53 expression in dysplastic BO epithelium, (G) 
weak nuclear and absent cytoplasmic RUNX3 expression in dysplastic BO epithelium, (H) 
ubiquitous HMGB1 expression in stromal lymphocyte populations in dysplastic BO biopsy, (I) 
CD20 positive lymphocytes, (J) CD8 positive lymphocytes, (K) CD4 positive lymphocytes and 
(L) FOXP3 positive lymphocytes.  
 
 
 
